Mice treated with interferon (IFN)-α, IL-2, IL-12, IL-15, or IL-18 showed an increase in NK cell cytotoxicity against multiple sarcoma cell subtypes, but few have been translated successfully to the clinic (34). Here, IL15 is linked to sarcoma.